3D printing technology is gradually leaving the laboratory and falling into practical medical applications.
On May 23, 2025, according to the resource database, Hospital Concord in Sydney, Australia, recently completed the first 3D skin transplant surgery in the world -based cells of patients, marking a major breakthrough in regenerative medicine in the field of burns. This technology not only reduces the pain of surgery, but also considerably improves the effectiveness of wound healing, bringing new hope to burn patients around the world.
It should be noted that this 3D printed skin transplant is not a simple surface repair, but high precision surgery that combines robotics and bio-engineering technology. The Concord hospital surgical project is deepened in collaboration with the Australian biotechnology company Inventia Life Science to use a 3D biopriting device specially developed for bedside scenarios.
The machine is based on the Ligō robot system owned inventia. It has high -precision and high cellular structure printing capacities. It can directly print the “bioink” containing the patient’s own cells on the layer of the plague area by layer, simulate the structure of the natural tissues of human skin and reach “the construction of the skin on demand”.
This technological transition from the “transplantation patch” to “in situ printing” is considered a key step in traditional skin transplant to a replacement for a complete biopritation.
The first patient recovered ideally, without almost any pain after surgery
The first person to undergo the transplant was an injured patient in a Kart accident. She reported after the operation: “There are almost no pain and the recovery speed exceeds expectations.” The doctor said that the new skin is lilac at first, but it will naturally transform towards a normal skin color over time. This case provides high validation of the clinical potential of technology.
The following judgment in regenerative medicine: printing bodies
The Concord Hospital plans to continue to carry out relevant treatments for five patients in the coming months and to collect clinical data more. The research team said that 3D skin printing is only the starting point and would move towards the printing of functional organs such as the liver and kidneys in the future to mitigate the shortage of global organs.
This breakthrough checks the feasibility of 3D printing in clinical medicine and opens up a new situation for regenerative medicine and personalized treatment. For industry, it is not only a sign of the implementation of technology, but also an important signal to promote industrial upgrade and medical reform. However, although technological performance is exciting, its widespread application must still solve several problems such as cost, equipment and ethics, and industry must still establish a regulatory framework corresponding to the future.
